Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Jun 10;74(11):2083-2084.
doi: 10.1093/cid/ciab890.

Lack of Antinuclear Antibodies in Convalescent Coronavirus Disease 2019 Patients With Persistent Symptoms

Affiliations
Comment

Lack of Antinuclear Antibodies in Convalescent Coronavirus Disease 2019 Patients With Persistent Symptoms

Michael J Peluso et al. Clin Infect Dis. .
No abstract available

PubMed Disclaimer

Comment in

  • Reply to Peluso et al.
    Seeßle J, Naujokat C, Oberacker P, Peters WH, Waterboer T, Müller B, Merle U. Seeßle J, et al. Clin Infect Dis. 2022 Jun 10;74(11):2084-2085. doi: 10.1093/cid/ciab892. Clin Infect Dis. 2022. PMID: 34617996 No abstract available.

Comment on

References

    1. Seeßle J, Waterboer T, Hippchen T, et al. . Persistent symptoms in adult patients one year after COVID-19: a prospective cohort study. Clin Infect Dis 2021. - PMC - PubMed
    1. Wallukat G, Hohberger B, Wenzel K, et al. . Functional autoantibodies against G-protein coupled receptors in patients with persistent long-COVID-19 symptoms. J Transl Autoimmun 2021; 4:100100. - PMC - PubMed
    1. Sacchi MC, Tamiazzo S, Stobbione P, et al. . SARS-CoV-2 infection as a trigger of autoimmune response. Clin Transl Sci 2021; 14:898-907. - PMC - PubMed
    1. Guilmot A, Maldonado Slootjes S, Sellimi A, et al. . Immune-mediated neurological syndromes in SARS-CoV-2-infected patients. J Neurol 2021; 268:751-7. - PMC - PubMed
    1. Peluso MJ, Kelly JD, Lu S, et al. . Rapid implementation of a cohort for the study of post-acute sequelae of SARS-CoV-2 infection/COVID-19. medRxiv 2021. doi:10.1101/2021.03.11.21252311. - DOI